Copyright Reports & Markets. All rights reserved.

Global Molecular Diagnostics and NAT Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Amplification Technologies
    • 1.4.3 Amplified Gene Detection Technologies
    • 1.4.4 DNA And Oligonucleotide Microarrays
    • 1.4.5 Gene Sequencing
  • 1.5 Market by Application
    • 1.5.1 Global Molecular Diagnostics and NAT Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and Clinics
    • 1.5.3 Research Institutes
    • 1.5.4 Diagnostic Centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Molecular Diagnostics and NAT Market Perspective (2015-2026)
  • 2.2 Global Molecular Diagnostics and NAT Growth Trends by Regions
    • 2.2.1 Molecular Diagnostics and NAT Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Molecular Diagnostics and NAT Historic Market Share by Regions (2015-2020)
    • 2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Molecular Diagnostics and NAT Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Molecular Diagnostics and NAT Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Molecular Diagnostics and NAT Players by Market Size
    • 3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2015-2020)
    • 3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Molecular Diagnostics and NAT Market Concentration Ratio
    • 3.2.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2019
  • 3.3 Molecular Diagnostics and NAT Key Players Head office and Area Served
  • 3.4 Key Players Molecular Diagnostics and NAT Product Solution and Service
  • 3.5 Date of Enter into Molecular Diagnostics and NAT Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2015-2020)
  • 4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Molecular Diagnostics and NAT Market Size by Application (2015-2020)
  • 5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Molecular Diagnostics and NAT Market Size (2015-2020)
  • 6.2 Molecular Diagnostics and NAT Key Players in North America (2019-2020)
  • 6.3 North America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 6.4 North America Molecular Diagnostics and NAT Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Molecular Diagnostics and NAT Market Size (2015-2020)
  • 7.2 Molecular Diagnostics and NAT Key Players in Europe (2019-2020)
  • 7.3 Europe Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 7.4 Europe Molecular Diagnostics and NAT Market Size by Application (2015-2020)

8 China

  • 8.1 China Molecular Diagnostics and NAT Market Size (2015-2020)
  • 8.2 Molecular Diagnostics and NAT Key Players in China (2019-2020)
  • 8.3 China Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 8.4 China Molecular Diagnostics and NAT Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Molecular Diagnostics and NAT Market Size (2015-2020)
  • 9.2 Molecular Diagnostics and NAT Key Players in Japan (2019-2020)
  • 9.3 Japan Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 9.4 Japan Molecular Diagnostics and NAT Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2015-2020)
  • 10.2 Molecular Diagnostics and NAT Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2015-2020)

11 India

  • 11.1 India Molecular Diagnostics and NAT Market Size (2015-2020)
  • 11.2 Molecular Diagnostics and NAT Key Players in India (2019-2020)
  • 11.3 India Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 11.4 India Molecular Diagnostics and NAT Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Molecular Diagnostics and NAT Market Size (2015-2020)
  • 12.2 Molecular Diagnostics and NAT Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
  • 12.4 Central & South America Molecular Diagnostics and NAT Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Roche
    • 13.1.1 Roche Company Details
    • 13.1.2 Roche Business Overview
    • 13.1.3 Roche Molecular Diagnostics and NAT Introduction
    • 13.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2015-2020))
    • 13.1.5 Roche Recent Development
  • 13.2 Abbott
    • 13.2.1 Abbott Company Details
    • 13.2.2 Abbott Business Overview
    • 13.2.3 Abbott Molecular Diagnostics and NAT Introduction
    • 13.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.2.5 Abbott Recent Development
  • 13.3 BD
    • 13.3.1 BD Company Details
    • 13.3.2 BD Business Overview
    • 13.3.3 BD Molecular Diagnostics and NAT Introduction
    • 13.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.3.5 BD Recent Development
  • 13.4 Biomerieux
    • 13.4.1 Biomerieux Company Details
    • 13.4.2 Biomerieux Business Overview
    • 13.4.3 Biomerieux Molecular Diagnostics and NAT Introduction
    • 13.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.4.5 Biomerieux Recent Development
  • 13.5 Qiagen
    • 13.5.1 Qiagen Company Details
    • 13.5.2 Qiagen Business Overview
    • 13.5.3 Qiagen Molecular Diagnostics and NAT Introduction
    • 13.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.5.5 Qiagen Recent Development
  • 13.6 Thermo Fisher Scientific
    • 13.6.1 Thermo Fisher Scientific Company Details
    • 13.6.2 Thermo Fisher Scientific Business Overview
    • 13.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction
    • 13.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.6.5 Thermo Fisher Scientific Recent Development
  • 13.7 Agilent
    • 13.7.1 Agilent Company Details
    • 13.7.2 Agilent Business Overview
    • 13.7.3 Agilent Molecular Diagnostics and NAT Introduction
    • 13.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.7.5 Agilent Recent Development
  • 13.8 GenMark
    • 13.8.1 GenMark Company Details
    • 13.8.2 GenMark Business Overview
    • 13.8.3 GenMark Molecular Diagnostics and NAT Introduction
    • 13.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.8.5 GenMark Recent Development
  • 13.9 Siemens Healthcare
    • 13.9.1 Siemens Healthcare Company Details
    • 13.9.2 Siemens Healthcare Business Overview
    • 13.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction
    • 13.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.9.5 Siemens Healthcare Recent Development
  • 13.10 AutoGenomics
    • 13.10.1 AutoGenomics Company Details
    • 13.10.2 AutoGenomics Business Overview
    • 13.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction
    • 13.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2015-2020)
    • 13.10.5 AutoGenomics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Molecular Diagnostics and NAT market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics and NAT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Roche
    Abbott
    BD
    Biomerieux
    Qiagen
    Thermo Fisher Scientific
    Agilent
    GenMark
    Siemens Healthcare
    AutoGenomics

    Market segment by Type, the product can be split into
    Amplification Technologies
    Amplified Gene Detection Technologies
    DNA And Oligonucleotide Microarrays
    Gene Sequencing
    Market segment by Application, split into
    Hospitals and Clinics
    Research Institutes
    Diagnostic Centers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now